Current knowledge on the genetics of incident venous thrombosis von Morange, P.‐E., Trégouët, D.‐A.

Volltext

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronar... von CUISSET, T., FRERE, C., QUILICI, J., BARBOU, F., MORANGE, P. E., HOVASSE, T., BONNET, J‐L., ALESSI, M‐C.

Volltext

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study von MORANGE, P. E, SIMON, C, ALESSI, M. C, LUC, G, ARVEILER, D, FERRIERES, J, AMOUYEL, P, EVANS, A, DUCIMETIERE, P, JUHAN-VAGUE, I

Volltext

Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism von Dennis, J., Truong, V., Aïssi, D., Medina‐Rivera, A., Blankenberg, S., Germain, M., Lemire, M., Antounians, L., Civelek, M., Schnabel, R., Wells, P., Wilson, M. D., Morange, P.‐E., Trégouët, D.‐A., Gagnon, F.

Volltext

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study von Suchon, P., Al Frouh, F., Ibrahim, M., Sarlon, G., Venton, G., Alessi, M.‐C., Trégouët, D.‐A., Morange, P.‐E.

Volltext

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk von Juhan‐Vague, I., Alessi, M‐C., Mavri, A., Morange, P. E.

Volltext

Is there still room for additional common susceptibility alleles for venous thromboembolism? von Trégouët, D. A., Delluc, A., Roche, A., Derbois, C., Olaso, R., Germain, M., Andrade, M., Tang, W., Chasman, D. I., Hylckama Vlieg, A., Reitsma, P. H., Kabrhel, C., Smith, N., Morange, P. E.

Volltext

Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels von MORANGE, P.‐E., SAUT, N., ANTONI, G., EMMERICH, J., TRÉGOUËT, D.‐A.

Volltext

Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease: The AtheroGene Study von Morange, P E, Bickel, C, Nicaud, V, Schnabel, R, Rupprecht, H J, Peetz, D, Lackner, K J, Cambien, F, Blankenberg, S, Tiret, L

Volltext

Association of Plasminogen Activator Inhibitor (PAI)-1 (SERPINE1) SNPs With Myocardial Infarction, Plasma PAI-1, and Metabolic Parameters: The HIFMECH Study von Morange, P E, Saut, N, Alessi, M C, Yudkin, J S, Margaglione, M, Di Minno, G, Hamsten, A, Humphries, S E, Tregouet, D A, Juhan-Vague, I

Volltext

Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study von Yudkin, J.S, Juhan-Vague, I, Hawe, E, Humphries, S.E, di Minno, G, Margaglione, M, Tremoli, E, Kooistra, T, Morange, P.E, Lundman, P, Mohamed-Ali, V, Hamsten, A

Volltext

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and South of Europe von JUHAN-VAGUE, I, MORANGE, P. E, DI MINNO, G, HAMSTEN, A, HUMPHRIES, S. E, AUBERT, H, HENRY, M, AILLAUD, M. F, ALESSI, M. C, SAMNEGARD, A, HAWE, E, YUDKIN, J, MARGAGLIONE, M

Volltext

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism von ANTONI, G., MORANGE, P.‐E., LUO, Y., SAUT, N., BURGOS, G., HEATH, S., GERMAIN, M., BIRON‐ANDREANI, C., SCHVED, J.‐F., PERNOD, G., GALAN, P., ZELENIKA, D., ALESSI, M.‐C., DROUET, L., VISVIKIS‐SIEST, S., WELLS, P. S., LATHROP, M., EMMERICH, J., TREGOUET, D.‐A., GAGNON, F.

Volltext

Lack of association of non‐synonymous FUT2 and ALPL polymorphisms with venous thrombosis von TREGOUET, D.‐A., SABATER‐LLEAL, M., BRUZELIUS, M., EMMERICH, J., AMOUYEL, P., DARTIGUES, J.‐F., KIELER, H., MORANGE, P.‐E.

Volltext

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study von Morange, P. E., Tregouet, D. A., Godefroy, T., Saut, N., Bickel, C., Rupprecht, H. J., Lackner, K., Barbaux, S., Poirier, O., Peiretti, F., Nalbone, G., Juhan-Vague, I., Blankenberg, S., Tiret, L.

Volltext

Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta‐analysis of eight studies von SMITH, N. L., HEIT, J. A., TANG, W., TEICHERT, M., CHASMAN, D. I., MORANGE, P.‐E.

Volltext

Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity von Morange, P E, Lijnen, H R, Alessi, M C, Kopp, F, Collen, D, Juhan-Vague, I

Volltext

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort von Morange, P. E., Tregouet, D. A., Frere, C., Saut, N., Pellegrina, L., Alessi, M. C., Visvikis, S., Tiret, L., Juhan‐Vague, I.

Volltext

The missing heritability of venous thrombosis: what about factor V Leiden heterogeneity? von Fautrad, P., Thomas, G. M., Morange, P. E.

Volltext

Plasma TAFI Antigen Variations in Healthy Subjects von Chetaille, P., Alessi, M. C., Kouassi, D., Morange, P. E., Juhan-Vague, I.

Volltext